CAR T Cells Retooled To Serve As ‘Micropharmacies’ For Cancer Drugs
Chimeric antigen receptor (CAR) T cell therapy is a type of immunotherapy that uses genetically modified versions of a person’s own immune cells to fight cancer. Current models of CAR T cells have several limitations, including a tendency to stop working after a period of time. A team of scientists at MSK’s Sloan Kettering Institute …